The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
"another transformational year for HRB" Sorry did I miss something since they reversed into PMO? I could have sold out then around £4 a share. Their payment of dividends & share buybacks (PMO also used to pay dividends and buy back their shares till they virtually went bust) may well prove to be a terrible mistake.
Nitro I think you are genuinely blinded. What about Wintershall bondholders or the German government and the possibility of the loss of jobs. ?Just 2 of many possible difficulties. The Deal is by no means a done deal IMO and looking at the share price in many other people's opinion as well.
Thanks for your post. I am very optimistic and have averaged down as I increased my holdings in this company.
I have faith in Directors as well, especially Alan Booth who IMO negotiated a good deal for Ophir (many might disagree) and an excellent sale of Encore Oil to Premier.